Integral Health Asset Management’s Tenax Therapeutics TENX Stock Holding History

Integral Health Asset Management’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.43M	Hold	167,000	–	–	0.1%	90
2026 Q1	$2.67M	Hold	167,000	–	–	0.13%	85
2025 Q4	$2.04M	Hold	167,000	–	–	0.1%	84
2025 Q3	$1.27M	Hold	167,000	–	–	0.09%	76
2025 Q2	$962K	Hold	167,000	–	–	0.09%	71
2025 Q1	$1.09M	Buy	+167,000	New	+$1.07M	0.12%	78

Other funds holding TENX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Integral Health Asset Management's TENX Position: Q2 2026 in Review

Integral Health Asset Management held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 167,000 shares worth $2.43M. The position accounts for 0.1% of the portfolio, ranked #90.

Integral Health Asset Management first reported a position in TENX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.67M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

Integral Health Asset Management held 167,000 shares of Tenax Therapeutics worth $2.43M as of Q2 2026.
Integral Health Asset Management left its Tenax Therapeutics share count unchanged in Q2 2026.
Tenax Therapeutics made up 0.1% of Integral Health Asset Management's portfolio in Q2 2026, its #90 holding.
Integral Health Asset Management first reported a position in Tenax Therapeutics in Q1 2025 and has held it in 6 quarters since.
Integral Health Asset Management's Tenax Therapeutics position peaked at $2.67M in Q1 2026.
111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.